Advertisement Cellectis bioresearch opens US subsidiary - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Cellectis bioresearch opens US subsidiary

Cellectis bioresearch, a specialist in genome customisation of the life science community and a subsidiary of Cellectis, has set up a new US subsidiary, Cellectis bioresearch Inc.

Cellectis bioresearch Inc, which is located at the Cambridge Innovation Center in Cambridge, Massachusetts, is expected to be responsible for the US-wide promotion of Cellectis bioresearch products and services.

Cellectis bioresearch’s products include its cellular Genome Positioning System (cGPS) and cGPS Custom targeted integration kits, which enable the engineering of cell lines with optimised features for drug discovery, protein production and gene function studies.

Eric Merle is expected to serve as sales director US and be in charge of recruiting and managing a team, covering the entire US market.